疾病修饰疗法对高度活跃的复发性复发性多发性硬化症的比较有效性,尽管先前的治疗 - - 一项系统性审查和网络元分析
Michael Köhler1, Friedemann Paul2, Kirsten Janke3
1Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany. michael.koehler@iqwig.de.
BMC neurology
|August 10, 2025
概括
对高度活跃的复发性复发性多发性硬化症 (RRMS) 的疾病修饰疗法 (DMT) 的比较评估揭示了显著的证据差距. 需要进一步的研究来为这种患者群体的治疗决策提供信息.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高活性复发性复发性多发性硬化症 (RRMS) 需要有效的疾病修饰疗法 (DMT).
- 对高度活跃的RRMS可用的DMT的比较数据有限,尽管一些疗法仅限于这一亚群.
研究的目的:
- 在高活性复发性复发性硬化症 (RRMS) 患者中对疾病修饰疗法 (DMT) 进行比较评估.
- 分析随机对照试验 (RCT) 中的个体患者数据 (IPD),以比较DMT的疗效.
主要方法:
- 在成年RRMS患者中系统地搜索对比已批准的DMT (alemtuzumab,cladribine,dimethyl fumarate,fingolimod,natalizumab,ocrelizumab,ofatumumab,ozanimod,ponesimod,teriflunomide) 的RCT.
- 纳入IPD的重新分析网络元分析 (NMAs) 在尽管之前有DMT,但疾病活性较高的子群体中.
- 应用高疾病活动的广泛标准,在研究中涵盖各种定义.
主要成果:
- 确定了14个相关的RCT,只有3个直接对DMT进行对比;没有发现纳塔利祖马布的研究.
- 对IPD的再分析对于综合性NMA是不够的,因为RCT的稀缺性,特别是对比试验,以及偏差的高风险.
- 缺乏有关患者相关结果和长期随访 (超过2年) 的数据.
结论:
- 一项利用最大可用的证据库的系统审查,包括未发表的数据,确定了高度活跃的RRMS中DMTs的实质性证据缺口.
- 这些发现突出了超出监管要求的进一步研究的关键需求,以更好地指导这种特定多发性硬化群体的治疗策略.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
232
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
232
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
01:28Drug Therapy
98
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
98
01:20Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
01:22Dose-Response Relationship: Potency and Efficacy
5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K